Ernest Mario - 30 Nov 2023 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Director
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
30 Nov 2023
Net transactions value
$0
Form type
4
Filing time
04 Dec 2023, 20:41:26 UTC
Previous filing
26 May 2023
Next filing
10 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Gift $0 -8,700 -6.4% $0.000000 128,089 30 Nov 2023 Direct F1, F2
holding SLNO Common Stock 20,752 30 Nov 2023 See footnote F3
holding SLNO Common Stock 0 30 Nov 2023 See footnote F4
holding SLNO Common Stock 0 30 Nov 2023 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares held directly no longer includes 20,752 shares which are now reported below as held by Mildred Mario Nonexempt Trust, of which the Reporting Person is a co-trustee.
F2 The number of shares beneficially owned has been reduced by one share pursuant to an internal review of the Reporting Person's holdings.
F3 The shares are held by Mildred Mario Nonexempt Trust, of which the Reporting Person is a co-trustee.
F4 The Reporting Person is no longer reporting indirect beneficial ownership of shares held by the by the Mario 1998 Irrevocable Trust, as the Reporting Person does not have beneficial ownership of such shares.
F5 The Reporting Person is no longer reporting indirect beneficial ownership of shares held by the by the Martha Mario Nonelective Trust, as the Reporting Person does not have beneficial ownership of such shares.